BRAINBox Solutions secures FDA breakthrough device designation for TBI test
BRAINBox Solutions announced that the US Food and Drug Administration (FDA) has granted breakthrough device designation for its…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
06 Jun 19
BRAINBox Solutions announced that the US Food and Drug Administration (FDA) has granted breakthrough device designation for its…
Mobidiag, a molecular diagnostics company, has partnered with Autobio Diagnostics, a China-based clinical diagnostics company, to launch the…
Myriad Genetics has released the results of its Phase III POLO study, which showed that BRACAnalysis CDx companion…
Caris Life Sciences has collaborated with Debiopharm to develop a companion diagnostic (CDx) for detection of rare fibroblast…
US-based Lumos Diagnostics has merged with RPS Diagnostics for the creation of a full service development company.
Roche has introduced first in vitro diagnostic immunohistochemistry (IHC) tests for the detection of ROS1 protein in cancers.
Germany-based sample and assay technologies provider QIAGEN has launched its PIK3CA RGQ PCR Kit (therascreen PIK3CA Kit) immediately…
Hologic and Cepheid have secured approval from the US Food and Drug Administration (FDA) for diagnostic tests for…
Royal Philips, an international health technology company, announced that Alverno Laboratories, a diagnostic testing services provider, has selected…
Gemelli Biotech, in partnership with the Medically Associated Science and Technology (MAST) program at Cedars-Sinai, announced new findings…